Company Overview
About Mammoth Biosciences
Mammoth Biosciences is a biotechnology company founded in 2017 by CRISPR pioneer and Nobel laureate Jennifer Doudna alongside Trevor Martin, Janice Chen, and Lucas Harrington. Headquartered in Brisbane, California, Mammoth focuses on developing ultracompact CRISPR systems that can be delivered in vivo using a single adeno-associated viral (AAV) vector — overcoming a major limitation of Cas9-based gene editors that are too large for efficient AAV delivery.
Business Model & Competitive Advantage
Mammoth''s flagship innovation is NanoCas, unveiled in January 2025 and described as the first efficient ultracompact extrahepatic gene editor. NanoCas efficiently edits skeletal muscle tissue in mice and non-human primates when delivered systemically — a breakthrough for treating muscular diseases and other extrahepatic conditions. The company also developed CasPhi, another ultracompact CRISPR nuclease significantly smaller than Cas9. Its lead clinical candidate, MB-111, is a potential first-in-class single-dose in vivo therapy for persistent chylomicronemia using CasPhi.
Competitive Landscape 2025–2026
In 2025, Mammoth presented preclinical data at ASGCT and the European Society of Gene & Cell Therapy congress, and announced a collaboration with Regeneron to pursue next-generation CRISPR-based gene editing across multiple diseases. Mammoth''s platform positions it as foundational infrastructure for the next wave of in vivo gene therapies targeting muscles, brain, and other organs where existing gene editing tools cannot reach.
Key Differentiators
Strong Challenger
Mammoth Biosciences is an established challenger with significant market presence and competitive offerings in Life Sciences & BioTech.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
Emulate
Emulate, Inc. is a Boston-based biotechnology company that designs, manufactures, and commercializes Organ-Chip technology — micro-engineered devices lined with living human cells that replicate the m
Neuralink
Neuralink is a neurotechnology company founded in 2016 by Elon Musk and a team of neuroscientists and engineers, developing implantable brain-computer interface devices that enable individuals with pa
Saluda Medical
Saluda Medical is a commercial-stage medical device company that has pioneered closed-loop neuromodulation therapy for chronic pain management. Headquartered in Macquarie Park, Australia (with US oper
Tempus
Tempus AI is a technology company applying artificial intelligence to advance precision medicine across oncology, neurology, psychiatry, and cardiology. Founded in 2015 by Eric Lefkofsky (co-founder o
Karius
Karius is a Redwood City, CA-based life sciences company founded in 2014 that developed the Karius Test — a single blood draw that uses next-generation sequencing and AI to detect over 1,000 pathogens
ConcertAI
ConcertAI is a Boston-based company that combines artificial intelligence with real-world oncology data to accelerate cancer drug development and improve patient outcomes. Its platform integrates mult
Compare Mammoth Biosciences with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Mammoth Biosciences? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Mammoth Biosciences Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Mammoth Biosciences vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →